Secondary
Intra-Cellular Therapies
J. P. Morgan Securities, Leerink Partners Description: Â Intra-Cellular Therapies is developing novel drugs for the treatment of neuropsychiatric and neurodegenerative diseases and diseases of the elderly, including Parkinsonâs and Alzheimerâs disease.
Symbol
ITCI (trades on OTC)
Last Closing Price
$19.23
Anticipated Date
TBD
Underwriters
J.P. Morgan, Leerink Partners
To view the prospectus for Intra-Cellular Therapies, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277